Pharmacology | Virology The search for new efficient inhibitors of SARS-COV-2 through the drug design developed by artificial intelligence. November 24, 2022
Public Health | Virology Persistent Laplacian projected Omicron BA.4 and BA.5 to become new dominating variants. November 15, 2022
Drug Development | Pharmacology | Virology Investigation of berberine and its derivatives in Sars Cov-2 main protease structure by molecular docking, PROTOX-II and ADMET methods: in machine learning and in silico study. November 12, 2022
Bioinformatics | Infectious Diseases | Virology D3AI-Spike: A deep learning platform for predicting binding affinity between SARS-CoV-2 spike receptor binding domain with multiple amino acid mutations and human angiotensin-converting enzyme 2. November 5, 2022
Drug Development | Virology Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen. November 1, 2022
Bioinformatics | Plant Pathology | Virology VirHunter: A Deep Learning-Based Method for Detection of Novel RNA Viruses in Plant Sequencing Data. October 29, 2022
Epidemiology | Infectious Diseases | Virology Emerging dominant SARS-CoV-2 variants. October 27, 2022
Bioinformatics | Pharmacology | Virology Identification of Diosmin and Flavin Adenine Dinucleotide as Repurposing Treatments for Monkeypox Virus: A Computational Study. October 19, 2022
Immunology | Virology Reduced B cell antigenicity of Omicron lowers host serologic response. October 12, 2022
Drug Discovery | Molecular Biology | Pharmacology | Virology Identification of promising anti-EBOV inhibitors: drug design, molecular docking and molecular dynamics studies. September 30, 2022
Pharmacology | Virology Development of a deep learning-based quantitative structure-activity relationship model to identify potential inhibitors against the 3C-like protease of SARS-CoV-2. September 30, 2022
Immunology | Pharmacology | Virology Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19. September 30, 2022